Indeed, Mdm2Adi+/− mice had lower circulating levels of MUP1 and decreased expression of Mup1 in their livers as confirmed by ELISA and qPCR, respectively (Fig. 2g, h) in agreement with the hepatic steatosis seen in these mice. Here, SLC25A19 is linked to fatty liver disease.